Trial Profile
Clinical study of apatinib mesylate tablets combined with chemotherapy in the treatment of platinum sensitive recurrent ovarian cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 05 Apr 2018 New trial record